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Abstract
Despite the establishment of the important role of nitric oxide (NO) on apoptosis, a molecular- level understanding of the
origin of its dichotomous pro- and anti-apoptotic effects has been elusive. We propose a new mathematical model for
simulating the effects of nitric oxide (NO) on apoptosis. The new model integrates mitochondria-dependent apoptotic
pathways with NO-related reactions, to gain insights into the regulatory effect of the reactive NO species N2O3, non-heme
iron nitrosyl species (FeLnNO), and peroxynitrite (ONOO
2). The biochemical pathways of apoptosis coupled with NO-related
reactions are described by ordinary differential equations using mass-action kinetics. In the absence of NO, the model
predicts either cell survival or apoptosis (a bistable behavior) with shifts in the onset time of apoptotic response depending
on the strength of extracellular stimuli. Computations demonstrate that the relative concentrations of anti- and pro-
apoptotic reactive NO species, and their interplay with glutathione, determine the net anti- or pro-apoptotic effects at long
time points. Interestingly, transient effects on apoptosis are also observed in these simulations, the duration of which may
reach up to hours, despite the eventual convergence to an anti-apoptotic state. Our computations point to the importance
of precise timing of NO production and external stimulation in determining the eventual pro- or anti-apoptotic role of NO.
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Introduction
The survival of an organism depends on homeostatic mecha-
nisms that establish a balance between cell proliferation and cell
death. Apoptosis, a form of programmed cell death, assists in
regulating cell proliferation. This process stands in contrast to
necrosis, which is thought to be uncontrolled. Dysregulation of
apoptosis has been implicated in various disease processes in which
the cells apoptose to a higher or lower extent compared to those in
healthy tissues [1]. When cells undergo apoptosis, a series of
morphological and biochemical changes occur, the mechanisms of
which are current topics of broad interest [2].
Apoptosis may be induced by various events, such as binding of
extracellular (EC) death signaling ligands to host cell receptors, the
lack of pro-survival signals, and genetic damage. These events are
usually followed by the activation of caspases, cysteine-dependent
aspartate-specific proteases, which initiate and execute apoptosis.
Caspases are activated through two major pathways: (a) ligand-
dependent or receptor-induced activation (extrinsic pathway),
involving death receptors such as Fas or the members of tumor
necrosis factor (TNF) receptor superfamily, and (b) mitochondria-
dependent activation (intrinsic pathway) via cytochrome c (cyt c)
release from mitochondria, triggered by stress, irradiation or
inflammation [3,4].
BindingofdeathligandssuchasFasligand (FasL),TNF,ortumor
necrosis-related apoptosis-inducing ligand (TRAIL) usually induces
the oligomerization of associated receptors, followed by binding of
adaptor proteins, e.g., Fas-Associated Death Domain proteins
(FADD), to the cytoplasmic domains of the receptors [5]. The
resulting Death Inducing Signaling Complex (DISC) recruits
multiple procaspase-8 molecules that mutually cleave and activate
one another into caspases-8 (casp8). In Type I cells, large quantities
of casp8 activate other caspases including the executioner caspase-3
(casp3) molecules that ultimately lead to apoptosis. In Type II cells,
on the other hand, the amount of casp8 activated at the DISC is
small, such that the activation of casp8 does not propagate directly
to casp3, but instead is amplified via the mitochondria.
Nitric oxide has opposite, competing effects in regulating
apoptosis: it exerts an anti-apoptotic effect on hepatocytes [6–8],
endothelial cells [9–13] and keratinocytes [14], whereas it is pro-
apoptotic in the case of macrophages [15–18]. The variability and
complexity of the effects of NO on ultimate cellular fate may arise
from this molecule’s ability to react with oxygen, reactive oxygen
species, metal ions, small thiol-containing molecules, and proteins.
The resulting reactive NO species can either trigger or suppress
apoptosis through various mechanisms. Chief among them is the
S-nitrosative suppression of caspase activation, subsequent to the
generation of FeLnNO or other species capable of carrying out S-
nitrosation reactions (see below) [7,19]. Differences in the levels of
NO and its reaction products may also arise from diverse
inflammatory settings in which the expression of nitric oxide
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cells express constitutive NOS (eNOS) that directly produce NO
molecules and mediate so-called ‘‘direct’’ effects [20]. Some
inflammatory stimuli, on the other hand, lead to inducible NOS
(iNOS) expression that subsequently generates reactive NO
species, which in turn mediate ‘‘indirect’’ effects of NO. The
simultaneous presence of oxygen radicals can generate other
reactive NO species that mediate further indirect effects of NO
[20]. As another example, hepatocytes and macrophages have
different amounts of non-heme iron complexes, which affect the
levels of iron-nitrosyl species when NO is produced [21]. Finally,
different intracellular levels of glutathione (GSH) can also
modulate the time evolution of NO-related compounds [22].
Computational approaches have been used previously to help
unravel the complex biology of NO. Biotransport of NO was first
modeled by Lancaster [23,24] followed by other groups, among
them Zhang and Edwards [25] (reviewed by Buerk [26]).
Recently, Hu and coworkers focused on detailed reaction
mechanism of NO [22]. These models have shed light into the
biotransport of NO and the types of chemical reactions that
involve NO and related reactive species. Additionally, a number of
mathematical models have been proposed for understanding the
mechanisms of apoptosis [27–35], including in particular the work
of Eissing et al., which demonstrated the importance of IAP
inhibition for imparting bistability in type I cells [30], and that of
Rehm et al. [33] and Legewie et al. [32] that showed the same
effect in type II cells. These studies have improved our
understanding of the robustness of switch mechanisms for
regulating apoptosis, but none of them has addressed the
dichotomous effects of NO [27–35].
Herein, we propose a mathematical model that may shed light
on the pro- and anti-apoptotic effects of NO in specific contexts.
The model we propose couples the apoptotic cascade [28] to an
extended model of NO reaction pathways initially proposed by Hu
et al. [22]. First, we illustrate how identical cells can undergo
apoptosis at different time points after being exposed to apoptotic
stimuli, in accord with experimental data collected on single cells
[36,37]. Then, we examine the apoptotic behavior in response to
changes in N2O3, FeLnNO, ONOO
2, and GSH levels in the
presence of NO production by iNOS. Our simulations provide
insights into the origin of the dichotomous effects of NO on
apoptosis observed in experiments.
Results
First, we illustrate how different strengths of EC pro-apoptotic
signals may result in opposite qualitative responses or different
quantitative (time-dependent) responses in the same type of cells
[37], using our recently introduced bistable model [28] (illustrated
in Figure 1A). Then, we examine the differences in the bistable
response of diverse NO producing cells, e.g. cells with different
concentrations of GSH and FeLn-and in different settings, i.e.,
with or without production of superoxide.
Delay in apoptosis induction (Model I)
Tyas et al. [37] showed that cells of the same type
simultaneously subjected to EC stimuli initiate their apoptotic
Figure 1. (A) Mitochondria-dependent apoptotic pathways in
Model I. The dotted box includes the interactions considered in the
model. Solid arrows indicate chemical reactions or upregulation; those
terminated by a bar indicate inhibition or downregulation; and dashed
arrows indicate subcellular translocation. The components of the model
are procaspase-8 (pro8), procaspase-3 (pro3), procaspase-9 (pro9),
caspase-8 (casp8), caspase-9 (casp9), caspase-3 (casp3), IAP (inhibitor of
apoptosis), cytochrome c (cyt c), Apaf-1, the heptameric apoptosome
complex (apop), the mitochondrial permeability transition pore
complex (PTPC), p53, Bcl-2, Bax, Bid, truncated Bid (tBid). The reader
is referred to our previous work [28] for more details. Three compounds
(N2O3, FeLnNO and ONOO
2) not included in the original Model I [28] are
highlighted. These compounds establish the connection with the nitric
oxide pathways delineated in panel B. (B) Nitric oxide (NO)-related
reactions in Model II. The following compounds are included: ONOO
2
(peroxynitrite), GPX (glutathione peroxidase), O2
2 (superoxide), GSH
(glutathione), GSNO (nitrosoglutathione), GSSG (glutathione disulfide),
CcOX (cytochrome c oxidase), SOD (superoxide dismutase), FeLn (non-
heme iron compounds), FeLnNO (non-heme iron nitrosyl compounds),
NADPH (reduced form of nicotinamide adenine dinucleotide phos-
phate), NADP+ (oxidized form of nicotinamide adenine dinucleotide
phosphate). FeLnNO, ONOO
2 and N2O3, highlighted in both panels A
and B, bridge between Models I to II. Model III integrates both sets of
reactions/pathways through these compounds. GSH modulates their
concentrations by reacting with them. GSH is converted by these
reactions to GSNO, which is then converted to GSSG and finally back to
GSH. Those compounds and interactions are shown in blue. See Table 1
for the complete list of reactions and rate constants.
doi:10.1371/journal.pone.0002249.g001
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theoretical time evolutions of casp3 in three identical cells
subjected to different strengths of EC apoptotic stimuli (repre-
sented here by the initial concentration of casp8) in the absence of
NO. For these simulations, we used Model I with three different
values of [casp8]0;1 0
25 mM, 10
24 mM, and 1.5610
24 mM in the
respective panels A–C, while [casp3]0 was 10
25 mM in all three
cases. Panel A shows that low [casp8]0 leads to the depletion of
[casp3], while [casp8]0 above a certain threshold (8.35610
25 mM)
(panels B and C) lead to increase in [casp3] and thereby onset of
cell death. Furthermore, comparison of panels B and C shows that
a relatively lower [casp8]0 (or weaker EC apoptotic signal) results
in a time-delayed initiation of apoptosis, in agreement with the
single cell experiments done by Tyas et al. [37]. The sharp
increase in [casp3] to its equilibrium level indeed starts about
30 minutes later in panel B, compared to panel C.
Next, we examined how this onset time varies with [casp8]0.
Figure 2D displays the results. An increase in onset time is predicted
with decreasing [casp8]0 up to [casp8]0=8.35610
25 mM, after
which no apoptotic effect is observed. The time delay is found to
obey a logarithmic decay with increasing D[casp8]0;[casp8]0–
8.35610
25 mM, as indicated by the best fitting curve.
This analysis shows that cells of the same type may undergo
apoptosis at different times due to their different EC microenviron-
ments. Hence, the difference in the onset times among cells of the
sametype in agiven cell culture may be explained without recourse to
alterations in the underlying network of biochemical reactions [28].
Nitric oxide-associated network (Model II) (Figure 1B)
The results from our calculations using Model II are shown in
Figure 3. Here, we focused on the time evolution of four
compounds, GSH, N2O3, FeLnNO and ONOO
2, displayed in
respective panels A–D. The NO species N2O3, FeLnNO and
ONOO
2 have been proposed to carry out various indirect effects
of NO on cellular pathways, including apoptosis, during
inflammation [20].
GSH is an anti-oxidant reduced to GSSG by reacting with
nitrosative N2O3 and FeLnNO, and with oxidative ONOO
2
(Table 1). GSH is depleted to low levels in a switch-like manner
due to those reactions (panel A). The depletion of GSH is
accompanied by increases in N2O3 and FeLnNO concentrations
(panels B–C). On the other hand, this switch-like behavior is not
that pronounced in [ONOO
2] time dependence (panel D).
Simulations performed with different initial GSH concentrations
(three different curves in each panel) change the steady-state
concentrations of all three NO-related compounds that interfere
with apoptotic pathways (panels B–D). The switch-like increase in
[N2O3] and non-switch-like increase in [ONOO
2] is in agreement
with the results of Hu et al. [22].
Anti-apoptotic and pro-apoptotic effects of NO (Model
III)
We analyze here the dynamics of the reduced mitochondria-
dependent apoptosis model coupled to anti- and pro-apoptotic
Figure 2. Time evolution of [casp3] predicted by a bistable
model in response to different strengths of apoptotic stimuli,
A) in a cell subjected to a weak EC apoptotic signal (reflected
by the low concentration [caps8]0); B) in a cell that is subjected
to a stronger EC pro-apoptotic signal. Caspase-3 is activated at
60 minutes; C) in a cell that is subjected to a stronger EC pro-apoptotic
signal than one in panel B. Caspase-3 is activated at 30 minutes. Panels
A and B illustrate two opposite effects induced by different initial
concentrations of caspase-8. The threshold concentration of [caps8]0
required for the switch from anti-apoptotic to pro-apoptotic response is
calculated to be 8.35610
25 mM. Panels B and C illustrate the shift in the
onset time of apoptosis depending on [casp8]0. D) Dependence of
apoptotic response time on the initial caspase-8 concentration. The
ordinate is the onset time of caspase-3 activation, and the abscissa is
the initial concentration of caspase-8 in excess of the threshold
concentration required for the initiation of apoptosis (evidenced by
increase in [casp3], see panels B–C). The onset time of caspase-3
activation exhibits a logarithmic decrease with D[casp8]0 ([casp8]0–
8.35610
25 mM).
doi:10.1371/journal.pone.0002249.g002
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list of reactions/interactions/steps that come into play in this
model (III). As mentioned above, NO-related pathways are
coupled to apoptotic pathways through N2O3, FeLnNO, and
ONOO
2 that are produced by the reaction of NO with O2, FeLn
and O2
2, respectively. For simplicity, those effects of NO
mediated by cGMP [38,39] are not included in this initial
mathematical model.
Modulating roles of N2O3 and GSH in apoptosis. We
initially excluded non-heme iron compounds in order to assess the
effect of N2O3 exclusively. The production rate of superoxide was
likewise assumed to be zero. N2O3 is produced by reactions (xii)
and (xiii) in Table 1. NO production and EC stimulation were
initiated simultaneously. Figures 4A–C are the counterparts of
Figures 2A–C, respectively (same initial conditions, except for the
interference of NO pathways through N2O3), where the time-
dependence of [casp3] (solid curve) and [GSH] are shown. The
bistable response to apoptotic stimuli, dependent on [casp8]0, is
shown to be maintained despite the interference of NO pathways
through N2O3. The three columns refer to different initial
concentrations of GSH, decreasing from [GSH]0=10
3 (Panels
A–C), to [GSH]0=10
2 (panels D–F) and GSH]0=0 (panels G–I).
The threshold [casp8]0 value for casp3 activation was
8.35610
25 mM in Figure 2, where NO was not produced at all.
This value remains the same for both [GSH]0=10
4 mM (not
shown) and 10
3 mM (panels A–C) in the presence of NO, but
increases to 9.9610
25 mM when [GSH]0 is 10
2 mM (panels D–F)
and to 1.26 610
24 mM when [GSH]0 is zero (panels G–I), hence
the different (pro-apoptotic) behavior observed in panel H.
These results suggest that N2O3 does not affect the bistable
character of the response to EC stimuli, except for modifying the
threshold for onset of apoptosis, which is shifted to higher [casp8]0
(i.e. rendered more difficult) with decreasing [GSH]0. However,
high initial concentrations of GSH restore the threshold back to
8.35610
25 mM. Therefore, N2O3 can serve as an effective
modulator of apoptosis provided that the level of GSH in the
system is sufficiently low.
Effect of N2O3 on the threshold degradation rates of Bax
for transition from bistable to monostable behavior. In
our previous computational study of apoptotic pathways, we
observed a bistable behavior (selecting between cell death and
survival) for degradation rates of Bax (mBax) lower than a threshold
value (0.11 s
21), while monostable cell survival was predicted
when mBax.0.11 s
21 (Figure 4A in Ref. [28]). This critical value of
Figure 3. Time evolutions of A) GSH, B) N2O3, C) FeLnNO, and D) ONOO
2 predicted by Model II. N2O3 and FeLnNO increase to high
concentrations by a switch-like mechanism induced by a decrease in GSH concentration due to conversion of GSH to GSNO and subsequently to
GSSG. [ONOO
2] does not follow a similar switch-like increase in its concentration. Solid curve is for [GSH]0=10
4 mM, dotted curve for [GSH]0=10
3 mM,
and dashed curve with diamonds for [GSH]0=10
2 mM. The response is thus sharper and earlier in the presence of lower initial concentrations of GSH.
doi:10.1371/journal.pone.0002249.g003
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limit point. We explored how the inclusion of NO reactions affects
these findings. The limit point value of the Bax degradation rate
for monostable cell survival is found to remain unchanged (at
0.11 s
21) for the range 10
3#[GSH]0#10
4 mM. However, it
decreases to 0.098 s
21 for [GSH]0=10
2 mM and 0.096 s
21 for
[GSH]0=0mM in the present model. The model again predicts
that N2O3 is not influential when the GSH level is sufficiently high
in the cell.
Roles of non-heme iron complexes and GSH in apoptotic
response. One of the important anti-apoptotic effects of NO is
presumed to occur via its ability to react with non-heme iron
complexes (FeLn) to form FeLnNO. These species inhibit caspases
by S-nitrosating the catalytic cysteine in the active site of these
enzymes [19,40,41].
The results are presented in Figure 5, panels A-F, organized
similarly to Figure 4 (i.e. using different [casp8]0 in each row, and
different [GSH]0 in the two columns). Our calculations suggest
that when the FeLn concentration is higher than 0.03 mM, there
are no longer two stable steady-states at long times: caspase-3
levels always decrease to zero, even though their time evolutions
depend on [casp8]0 and [GSH]0. Yet, depending on the level of
GSH, both apoptosis and cell survival may be possible. Panels A–
C correspond to relatively high [GSH]0. In panel A, [casp3]
decreases to 10
28 mM that is less than 1 molecule per cell, hence
zero, from 10
25 mM within the first two hours. However, in panels
B and C, [casp3] increases to nanomolar values and remains at
those levels for more than three hours. Caspase-3 may cause
enough damage to kill the cell before it is depleted at longer times.
We note that lower [GSH]0 (e.g. [GSH]0=10
3 mM, panels D–F
and [GSH]0,10
3 mM, data not shown) do not permit the casp3
concentration to reach such pro-apoptotic levels and monostable
cell survival is observed irrespective of [casp8]0.
Various cell types subject to different intracellular microenvi-
ronments, or even the same cells under different settings (e.g.
healthy state vs. inflammation or oxidative stress), may produce or
experience different reactive NO intermediates [7,20,42]. For
example, more FeLnNO may be produced in hepatocytes than in
RAW264.7 macrophage-like cells due to the high level of non-
heme iron complexes in hepatocytes [21]. In our previous study,
RAW264.7 cells underwent apoptosis in the presence of NO;
conversely, no casp3 activation was observed in either hepatocytes
or iron loaded RAW264.7 cells [21]. The results (Figure 4 and
data not shown) suggest that in cells with iron concentrations lower
than 0.03 mM (e.g. RAW264.7 cells), both cell survival and
apoptosis are possible depending on the strength of apoptotic
stimuli (in agreement with our experimental results) [21].
However, a change in the intracellular environment of the same
cell can change the response. Figure 5D–F shows that casp3 is not
activated in the presence of non-heme iron ([FeLn]0=0.05 mM)
when [GSH]0=10
3 mM and [GSH]0,10
3 mM (data not shown).
We also checked if casp3 is activated when [casp8]0 is as high as
0.1 mM when [GSH] =10
3 mM. In this case, caspase-3
concentration increased to 0.0007 mM for approximately 5 min-
utes, an apoptotic stimulus that is likely insufficient for apoptosis.
This prediction is in good agreement with our observation that
caspase-3 is not activated in non-heme iron-loaded RAW264.7
cells whose [GSH]0 does not reach 10
4 mM [21].
Roles of ONOO
2 and GSH in apoptotic response. The
mechanism by which NO or its reactive species exert pro-
Table 1. Reactions in Model II
Description of the reaction/interaction Rate constant (*) Reference Reaction index
Production of NO k1NO=1mM/s [22] (i)
Production of O2
2 k2NO=0.1mM/s [22] (ii)
Production of GSH k3NO=0 [22] (iii)
NO+O2
2RONOO
2 k4NO=6700 mM
21s
21 [56] (iv)
SOD+O2
2+H
+RSOD+K O2+K H2O2 k5NO=2400 mM
21s
21 [57] (v)
ONOO
2+GSHRGSNO+products k6NO=0.00135 mM
21s
21 [58] (vi)
ONOO
2+GPXRGPX+products k7NO=2mM
21s
21 [59] (vii)
ONOO
2+CO2Rproducts k8NO=0.058mM
21s
21 [60,61] (viii)
ONOO
2+cyt cRcyt c+products k9NO=0.025mM
21s
21 [62] (ix)
2GSNO+O2
2+H2ORGSSG+products k10NO=0.0006 mM
22s
21 [63] (x)
N2O3+GSHRGSNO+NO2
2+H
+ k11NO=66mM
21s
21 [64] (xi)
2NO+O2R2NO2 k12aNO=0.000006 mM
22s
21 [65] (xii)
NO2+NO « N2O3 k12bNO
+=1100 mM
21s
21 [65] (xiii)
k12bNO
2=81000 s
21
N2O3+H2ORproducts k13NO=1600 s
21 [65,66] (xiv)
GSSG+NADPH+H
+R2GSH+NADP
+ Vm=320 mMs
21 [67] (xv)
Km=50mM
Cu
+ GSNORK GSSG+NO k14NO=0.0002s
21 [68,69] (xvi)
CcOx+NORCcOX.NO k15NO=100 mM
21s
21 [70] (xvii)
FeLn+NORFeLnNO k16NO=1.21 mM
21s
21 [71] (xviii)
FeLnNO+GSHRGSNO+FeLn k17NO=66mM
21s
21 a [72] (xix)
GSH+O2
2RK GSSG+products k17bNO=0.0002 mM
21s
21 [73] (xx)
aSame as k11NO
doi:10.1371/journal.pone.0002249.t001
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we assume that the pro-apoptotic effect of NO occurs via
formation of ONOO
2, as has been suggested from a large
number of experimental studies both in vitro and in vivo [44,45].
Experimental studies suggest that ONOO
2 may induce the
opening of mitochondrial permeability transition pores (MPTPs)
and subsequent cyt c release from mitochondria [38].
The possible mechanisms of cyt c release from mitochondria are
diverse and controversial [46,47]. In our model, we assume that
cyt c release is mediated by activation of MPTPs, independent of
Bax channel formation on mitochondria. The complex that forms
the MPTPs is called mitochondrial permeability transition pore
complex (PTPC). The complex consists of peripheral benzodiaz-
epine receptor, cyclophilin D, adenine nucleotide translocator
(ANT), voltage-dependent anion channel (VDAC), and other
proteins [48]. ANT is proposed to be converted from a specific
transporter to a non-specific pore which then releases cyt c into the
cytoplasm and subsequently induces apoptosis. It has been
suggested that ONOO
2 acts on PTPC, specifically on ANT, to
convert it to a non-specific pore (PTPCact) [49]. We represent this
process as:
ONOO
zPTPC?PTPCactzproducts
Cytochrome c is then released from the pore formed by PTPCact
cyt cmitozPTPCact?cyt czPTPCact
The results are shown in Figure 6. The initial concentration of
PTPC is assumed to be high (0.01 mM). At that value, Model I
predicts the response to apoptotic stimuli to be monostable
apoptosis (Figure 6 in Ref. [28]). We see a similar response in
Figure 6A; a low initial value of casp8 (10
25 mM) results in an
increase of [casp3] to nanomolar levels. Casp3 activation was
observed with even lower values of [casp8]0. However, casp3 does
not reach nanomolar concentrations when [GSH]0=10
3 mM
(Figures 6D–F) and [GSH]0,10
3 mM (data not shown). Initial
concentrations [casp8]0 higher than 1.5610
24 mM did not change
this prediction.
These results suggest that in cells with large numbers of MPTPs
(probably with high numbers of mitochondria), there are two
possible outcomes in the presence of NO and O2
2 production:
Figure 4. Time evolutions of [GSH] and [casp3] predicted by Model III in the presence of N2O3 effects. Here, in order to visualize the
effect of N2O3 exclusively, the reaction (xxii) in Table 4 is included in the model while those involving FeLnNO and ONOO
2 (reactions (xx, xxiii-xxv) are
not, assuming FeLn concentration and rate of formation of superoxide to be zero. The solid curves depict the time evolution of [casp3], and dotted
curves refer to [GSH]. The three rows of panels are the counterparts of those in Figure 2 A–C, with the different columns referring to different initial
concentrations of GSH: A–C) [GSH]0=10
3 mM; D–F) [GSH]0=10
2 mM; G–I) [GSH]0=0mM.
doi:10.1371/journal.pone.0002249.g004
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4 mM) and
solely cell survival when GSH level is low ([GSH]#10
3 mM) in the
presence of O2 and FeLn. This result stands in contrast with
studies in which GSH protects against oxidative stress (high
concentrations of O2
2 and ONOO
2) that can cause apoptosis.
The reason for this paradoxical prediction is that GSH has both
protective and pro-apoptotic effects in our simulations: it exerts
apoptotic effects via its reaction with anti-apoptotic N2O3 and
FeLn, and protective effects due to its reaction with pro-apoptotic
O2
2 and ONOO
2. Simulations (Figure 6) suggest that the pro-
apoptotic effect of GSH is stronger than its protective effect using
the interactions and parameters adopted in current simulations.
To examine the possibility of an alternative response, we
repeated the computations depicted in Figure 6 in the absence of
O2 (so that N2O3 is not produced) and FeLn. We also used initial
PTPC concentration of 0.0001 mM, at which Model I predicts
bistability (Figure 6 in ref [28]). As seen in Figure 7, both cell
survival and apoptosis are possible under these conditions,
depending on [casp8]0. Higher [GSH]0 (10
4 mM) results in cell
survival (Figure 7B) in contrast to lower [GSH]0 resulting in
apoptosis (Figure 7E) under the same amount of EC stimulus
([casp8]0=7 610
25 mM). The present analysis thus shows that the
protection by GSH against oxidative stress is possible provided
that O2 and FeLn levels are sufficiently low.
Discussion
We present here the results from simulations that incorporate
the main chemical interactions of NO with components of the
apoptotic interactions network, with the goal of shedding light on
the dichotomous effects of NO on apoptosis. Based on previously
published studies, we considered N2O3 and FeLnNO to be anti-
apoptotic and ONOO
2 pro-apoptotic. The results predict that cell
survival or apoptosis is determined by a complex interplay among
these reactive NO species and GSH. We observed that relative
concentrations of anti-apoptotic and pro-apoptotic species deter-
mine the ultimate cell fate at late time points. Interestingly,
transient apoptotic effects were observed under specific conditions
(e.g. Figure 5 panels B–C). These intriguing findings point to the
importance of the timing of NO production and apoptotic stimuli in
determining the actual anti- or pro-apoptotic effect, even if steady
state conditions favor cell survival, in agreement with our previous
observations [50–52]. Another interesting effect we observed in
our simulations was the time shift/delay in the onset of apoptosis
in the presence of weak EC stimulus (panel B–D in Figure 2),
consistent with the experiments of Tyas et al. [37].
Our simulations suggest that N2O3 and non-heme iron nitrosyl
form in a switch-like manner after depletion of GSH. ONOO
2
formation, on the other hand, hardly shows any switch-like
Figure 5. Time evolutions of [GSH] and [casp3] predicted by Model III in the presence of N2O3 and FeLnNO. N2O3 is present in the
model ([O2] is non-zero) as well as FeLnNO ([FeLn]0 is non-zero). Each column is a counterpart of Figure 2A–C with different initial concentrations of
GSH. A–C) [GSH]0=10
4 mM; D–F) [GSH]0=10
3 mM. Solid curve shows the time evolution of [casp3] and dotted curve that of [GSH].
doi:10.1371/journal.pone.0002249.g005
Effects of NO on Apoptosis
PLoS ONE | www.plosone.org 7 May 2008 | Volume 3 | Issue 5 | e2249behavior. We further found that N2O3 does not eliminate the
bistability between cell survival and apoptosis, but rather increases
the threshold [casp8]0 for onset of apoptosis. However, high initial
concentrations of GSH restore the threshold back to its original
value. Therefore, we would predict, non-intuitively, that N2O3
does not influence cell survival when [GSH]0 level is high.
On the other hand, our simulations suggest that there are no
longer two stable steady states (cell survival and apoptosis) in the
presence of non-heme iron at a level higher than a threshold value.
Caspase-3 levels always decrease to zero even though its time
evolution may depend on [casp8]0 and [GSH]0. Yet, despite the
steady state conditions that favor cell survival, executioner caspase
concentrations can reach and retain apoptotic levels for several
hours before they level off, when [GSH]0 is high. When [GSH]0 is
low, on the other hand, our simulations predict resistance to
apoptosis, in agreement with experimental observation [21].
In cells with high numbers of MPTPs (probably cells that
contain high numbers of mitochondria), our simulations suggest
two possibilities in the presence of simultaneous NO and O2
2
production and sufficiently high [FeLn]0: pathological cell death
when [GSH]0 is high (10
4 mM) or solely cell survival when [GSH]0
level is low ([GSH]0#10
3 mM). On the other hand, GSH is
protective against oxidative stress when O2 and FeLn levels are low
in cells with low numbers of MPTPs.
Tiedge et al. [53] have shown that pancreatic beta cells have
low anti-oxidant levels (notably, GSH) and that the number of
mitochondria is a determining factor in survival. They have also
shown that transfection of the cells with a peroxide-inactivating
enzyme, catalase, can protect against high-glucose induced
apoptosis. An interesting experiment would be to correlate the
number of mitochondria in the transfected cells with their survival.
Oyadomari et al. [54] have shown that the endoplasmic reticulum
(ER) plays a crucial role in the fate of NO-sensitive beta cells via
calcium signaling. A natural next step in the present model would
be to include these effects via a model which incorporates the
effects of NO on the ER.
Our results are subject to several limitations. While we have
adopted values for kinetic parameters and concentrations in
accord with experimental data whenever available (Tables 1 and
2), many of the true intracellular rate constants for the reactions in
our simulations are unknown. Given that the observed apoptotic
responses are so sensitive to model parameters, detailed knowledge
of reaction mechanisms and accurate values of rate constants are
needed in modeling reaction networks as complicated as the ones
Figure 6. Time evolutions of [GSH] and [casp3] predicted by Model III in the presence of N2O3, FeLnNO and ONOO
2. The initial
concentration of PTPC is 0.01 mM. Each column is a counterpart of Figure 2A–C and has a different initial concentration for GSH. A–C)
[GSH]0=10
4 mM; D–F) [GSH]0=10
3 mM. Solid line is for time evolution of [casp3] and dashed line is for time evolution of [GSH]. Caspase-3
concentrations at long times are 2.4 610
24 mM and 2.5610
28 mM for panels A–C and D–F, respectively.
doi:10.1371/journal.pone.0002249.g006
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posited that the pro-apoptotic NO species is ONOO
2; however,
other species may in fact exert this effect. Additionally, the
hypotheses raised by our simulations remain to be tested by further
experiments. Some of the predictions could be tested by iron
chelation and/or treatment with superoxide donors in a cell-free
system or in single-cell studies, though each of these manipulations
may have additional, artifactual effects. The hypothesis of
bistability with regards to the apoptotic response can be tested
as suggested by Legewie et al. [32], either in cell free-systems by
adding caspase-3 or in single living cells by microinjecting caspase-
3. The time evolution of caspase-3 can be monitored by
fluorescent caspase-3 substrates. The time needed for caspase-3
activation will increase abruptly as caspase-3 concentration added
will approach threshold value in a bistable system (Figure 2D).
Such combined experimental and computational studies may
potentially help us understand and design therapeutics for diseases
associated with apoptosis dysregulation.
Materials and Methods
Models
Three models are considered in this study. Model I, proposed
in our earlier work [28], focuses on the pathways involved in
mitochondria-dependent apoptosis (Figure 1A). Model II is an
extension of the kinetic model of NO-associated reactions recently
proposed by Hu et al. [22] (Figure 1B). Finally, Model III is the
integration of Models I and II, proposed in the present study, to
examine the pro-apoptotic and anti-apoptotic effects of NO.
Figure 7. Time evolutions of [GSH] and [casp3] predicted by Model III in the absence of N2O3, FeLnNO and presence of ONOO
2. The
initial concentration of PTPC is 0.0001 mM. A–C) [GSH]0=10
4 mM; D–F) [GSH]0=10
2 mM. Solid line is for time evolution of [casp3] and dashed line is
for time evolution of [GSH].
doi:10.1371/journal.pone.0002249.g007
Table 2. Equilibrium levels and initial concentrations used in
Model II
Equilibrium concentrations References
[SOD]‘=10mM[ 74]
[GPX]‘=5.8mM[ 67]
[CO2]‘=10
3 mM[ 61]
[O2]‘=35mM[ 67]
[cyt c]‘=400mM[ 75]
Initial concentrations References
[CcOx]0=0.1mM[ 76]
[FeLn]0=0.05 mM[ 77]
[GSH]0=10
4 mM (or otherwise specified) [22]
doi:10.1371/journal.pone.0002249.t002
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steps) are modeled using mass action kinetics theory and methods.
The simulations are performed using XPPAUT software (http://
www.math.pitt.edu/,bard/xpp/xpp.html) [55].
Model II-Generation of NO-related oxidative and
nitrosative species ONOO
2,N 2O3, and FeLnNO
We extended the network originally proposed by Hu and
coworkers [22] by introducing additional reactions involving NO,
as well as additional compounds such as the NO-related species
FeLnNO (L denotes ligands that do not contain heme), NO2, and
cytochrome c oxidase (CcOx). Figure 1B illustrates the extended
network of interactions. Table 1 lists the corresponding reactions
(indexed as (i)–(xx)) and rate constants. The reactions (xii) and (xiii)
break down the production of N2O3 from NO and O2 into two
steps that replace the corresponding reaction (with rate constant
k12) used in the model of Hu et al. [22]. Reactions (xvi)–(xx) are
introduced in the present study. The identity of the products are
not written when these compounds do not serve as reactants in any
of the reactions listed in Table 1. Table 3 lists the rate laws for
these reactions (the first 20 rows), which are used in the differential
rate equations (rows 21–29) that control the time evolution of the
concentration of the individual compounds. Model II contains 16
components. Eleven of them reach steady-state concentrations
Table 3. Rate equations for Model II (*)
Rate laws (Eq.s 1–20) and differential rate equations
(Eq.s 21–29)
Equation
numbers
r1NO=k 1NO (1)
r2NO=k 2NO (2)
r3NO=k 3NO (3)
r4NO=k 4NO[NO][O2
2]( 4 )
r5NO=k 5NO[SOD][O2
2]( 5 )
r6NO=k 6NO[ONOO
2][GSH] (6)
r7NO=k 7NO[ONOO
2][GPX] (7)
r8NO=k 8NO[ONOO
2][CO2]( 8 )
r9NO=k 9NO[ONOO
2][cyt c]( 9 )
r10NO=k 10NO[GSNO]
2[O2
2]( 1 0 )
r11NO=k 11NO[N2O3 ][GSH] (11)
r12aNO=k 12aNO[NO]
2[O2]( 1 2 )
r12bNO
+=k 12bNO
+[NO2][NO] (13)
r12bNO
2=k 12bNO
2[N2O3]( 1 4 )
r13NO=k 13NO[N2O3]( 1 5 )
rm=V m[GSSG]/(Km+[GSSG]) (16)
r14NO=k 14NO[GSNO] (17)
r15NO=k 15NO[CcOx][NO] (18)
r16NO=k 16NO[FeLn][NO] (19)
r17NO=k 17NO[FeLnNO][GSH] (20)
d[NO]/dt=r1NO–r4NO–2r12aNO–r12bNO
++r12bNO
2+r14NO –r15NO–r16NO (21)
d[O2
2]/dt=r2NO–r4NO–r5NO–r10NO (22)
d[ONOO
2]/dt=r4NO–r6NO–r7NO–r8NO–r9NO (23)
d[GSH]/dt=r3NO–r6NO–r11NO+2rm–r17NO (24)
d[GSNO]/dt=r6NO–2r10NO+r11NO –r14NO+r17NO (25)
d[N2O3]/dt =–r11NO+r12bNO
+–r12bNO
2–r13NO (26)
d[NO2]/dt=2r12aNO–r12bNO
++r12bNO
2 (27)
d[CcOx]/dt =–r15NO (28)
d[FeLn]/dt=–r16NO+r17NO (29)
(
*) Note that [FeLnNO]=[FeLn]02[FeLn], and [GSSG]=([GSH]0–[GSH]–[GSNO])/2
doi:10.1371/journal.pone.0002249.t003
Table 4. Reactions bridging between Models I to II (*)
Reaction Rate constant Reference Reaction index
ONOO
2+PTPCRPTPCact+products k18NO accounts for ONOO
2 induced formation of
non-specific pore associated with
mitochondrial permeability transition [49]
(xxi)
N2O3+casp8Rcasp8.NO+FeLn k19NO [78] (xxii)
FeLnNO+casp8Rcasp8.NO+FeLn k20NO [38] (xxiii)
FeLnNO+casp9Rcasp9.NO+FeLn k21NO [38] (xxiv)
FeLnNO+casp3Rcasp3.NO+FeLn k22NO [38] (xxv)
(
*) The parameters used in the present study are k18NO=1mM
21s
21 (varying the value between 0.01 mM
21s
21 and 100 mM
21s
21 does not affect the results),
k19NO=10mM
21s
21 [78], k20NO=k 21NO=k 22NO=66mM
21s
21 (the same value as k11NO).
doi:10.1371/journal.pone.0002249.t004
Table 5. The modified equations from either Model I or II (*)
Rate laws (Eq.s 30–34) and differential rate equations
(Eq.s 35–43)
Equation
numbers
r18NO=k 18NO[ONOO
2][PTPC] (30)
r19NO=k 19NO[N2O3][casp8] (31)
r20NO=k 20NO[FeLnNO][casp8] (32)
r21NO=k 21NO[FeLnNO][casp9] (33)
r22NO=k 22NO[FeLnNO][casp3] (34)
d[ONOO
2]/dt=r4NO–r6NO–r7NO–r8NO–r9NO–r18NO (35)
d[PTPC]/dt=–r19NO (36)
d[N2O3]/dt =–r11NO+r12bNO
+–r12bNO
2–r13NO–r19NO (37)
d[casp8]/dt =2J0+J0
f+Jcasp8–r19NO–r20NO (*) (38)
d[FeLnNO]/dt=r16NO–r17NO–r20NO–r21NO–r22NO (39)
d[FeLn]/dt =–r16NO+r17NO+r20NO+r21NO+r22NO (40)
d[casp9]/dt=J4 –J4b–J5–J6 +J6
f+Jcasp9–r21NO (*) (41)
d[casp3]/dt=J6
f+J6b
f–J7 –J8+J8
f–J9+J9
f+Jcasp3–r22NO (*) (42)
d[cyt c]/dt=J14–J1+Jcytc+k[PTPCact][cyt cmit]
where k=1 mM
21s
21 (*)
(43)
(
*) J refers to fluxes of components, for details see ref [28]. PTPCact refers to the
nonspecific pore at the mitochondria that releases cyt c. Note that
[PTPCact]=[PTPC]0–[PTPC].
doi:10.1371/journal.pone.0002249.t005
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simulations for [GSH]0#10
3 mM and within four and half hours
for [GSH]0=10
4 mM, whereas five compounds (superoxide
dismutase (SOD), glutathione peroxidase (GPX), CO2,O 2, and
cyt c) retain their equilibrium concentrations. Table 2 lists the
initial and equilibrium concentrations different from zero, adopted
in Model II, and the corresponding references.
Model III–Effects of NO-related reactions on apoptotic
pathways
Model III combines Models I and II upon inclusion of the
additional reactions presented in Table 4. See the highlighted
compounds in Figure 1, which point to the species that couple the
apoptotic and NO pathways. We note that ONOO
2 has a pro-
apoptotic effect, while N2O3 and FeLnNO (reactions labeled
(xxii)–(xxv)) deactivate the caspases, thus inducing anti-apoptotic
effects. The associated rate constants and references are given in
Table 4. Table 5 provides the rate expressions (rows 30–34) and
differential rate equations (rows 35–43) for these reactions and
involved compounds, respectively.
The steady-state concentrations [H
+]‘ in reaction (v), [H2O]‘
in reactions (x) and (xiv), [NADPH]‘ and [H
+]‘ in reaction (xv),
[Cu
+]‘ in reaction (xvi) are incorporated into the corresponding
rate constants.
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